Gut microbiota-derived short-chain fatty acids and their role in human health and disease
Gill, S. K., Rossi, M., Bajka, B. & Whelan, K. Dietary fibre in gastrointestinal health and disease. Nat. Rev. Gastroenterol. Hepatol. 18, 101–116 (2021).
Google Scholar
Louis, P., Solvang, M., Duncan, S. H., Walker, A. W. & Mukhopadhya, I. Dietary fibre complexity and its influence on functional groups of the human gut microbiota. Proc. Nutr. Soc. 80, 386–397 (2021).
Google Scholar
Glover, J. S., Ticer, T. D. & Engevik, M. A. Characterizing the mucin-degrading capacity of the human gut microbiota. Sci. Rep. 12, 8456 (2022).
Google Scholar
Zhang, D. et al. Short-chain fatty acids in diseases. Cell Commun. Signal. 21, 212 (2023).
Google Scholar
Hodgkinson, K. et al. Butyrate’s role in human health and the current progress towards its clinical application to treat gastrointestinal disease. Clin. Nutr. 42, 61–75 (2023).
Google Scholar
Drula, E. et al. The carbohydrate-active enzyme database: functions and literature. Nucleic Acids Res. 50, D571–D577 (2022).
Google Scholar
Ndeh, D. & Gilbert, H. J. Biochemistry of complex glycan depolymerisation by the human gut microbiota. FEMS Microbiol. Rev. 42, 146–164 (2018).
Google Scholar
Louis, P. & Flint, H. J. Formation of propionate and butyrate by the human colonic microbiota. Environ. Microbiol. 19, 29–41 (2017).
Google Scholar
Frolova, M. S., Suvorova, I. A., Iablokov, S. N., Petrov, S. N. & Rodionov, D. A. Genomic reconstruction of short-chain fatty acid production by the human gut microbiota. Front. Mol. Biosci. 9, 949563 (2022). This study utilizes human faecal metagenomic data sets to perform an in-depth in silico analysis of SCFA fermentation pathways in different populations.
Google Scholar
Reichardt, N. et al. Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. ISME J. 8, 1323–1335 (2014).
Google Scholar
Bui, T. P. N. et al. Production of butyrate from lysine and the Amadori product fructoselysine by a human gut commensal. Nat. Commun. 6, 10062 (2015).
Google Scholar
Louis, P., Duncan, S. H., Sheridan, P. O., Walker, A. W. & Flint, H. J. Microbial lactate utilisation and the stability of the gut microbiome. Gut Microbiome 3, e3 (2022).
Google Scholar
Wang, S. P. et al. Pivotal roles for pH, lactate, and lactate-utilizing bacteria in the stability of a human colonic microbial ecosystem. mSystems 5, 1–18 (2020).
Google Scholar
Hackmann, T. J. New biochemical pathways for forming short-chain fatty acids during fermentation in rumen bacteria. JDS Commun. 5, 230–235 (2024).
Google Scholar
Walker, A. W., Duncan, S. H., McWilliam Leitch, E. C., Child, M. W. & Flint, H. J. pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon. Appl. Environ. Microbiol. 71, 3692–3700 (2005).
Google Scholar
Duncan, S. H., Louis, P., Thomson, J. M. & Flint, H. J. The role of pH in determining the species composition of the human colonic microbiota. Environ. Microbiol. 11, 2112–2122 (2009).
Google Scholar
LaBouyer, M. et al. Higher total faecal short-chain fatty acid concentrations correlate with increasing proportions of butyrate and decreasing proportions of branched-chain fatty acids across multiple human studies. Gut Microbiome 3, e2 (2022).
Google Scholar
Flint, H. J., Louis, P. & Duncan, S. H. Why does increased microbial fermentation in the human colon shift toward butyrate? AIMS Microbiol. 10, 311–319 (2024).
Google Scholar
Campbell, A., Gdanetz, K., Schmidt, A. W. & Schmidt, T. M. H2 generated by fermentation in the human gut microbiome influences metabolism and competitive fitness of gut butyrate producers. Microbiome 11, 133 (2023).
Google Scholar
Joos, R. et al. Examining the healthy human microbiome concept. Nat. Rev. Microbiol. 23, 192–205 (2024).
Google Scholar
Park, S.-Y. et al. Strain-level fitness in the gut microbiome is an emergent property of glycans and a single metabolite. Cell 185, 513–529.e21 (2022). Using in vitro and in vivo approaches, this study demonstrates the unique fitness landscape of different Bacteroides strains based on their response to butyrate in the presence of different glycan substrates.
Google Scholar
Chung, W. S. F. et al. Impact of carbohydrate substrate complexity on the diversity of the human colonic microbiota. FEMS Microbiol. Ecol. 95, fiy201 (2019).
Google Scholar
Puhlmann, M.-L. & de Vos, W. M. Intrinsic dietary fibers and the gut microbiome: rediscovering the benefits of the plant cell matrix for human health. Front. Immunol. 13, 954845 (2022).
Google Scholar
So, D. et al. Detection of changes in regional colonic fermentation in response to supplementing a low FODMAP diet with dietary fibres by hydrogen concentrations, but not by luminal pH. Aliment. Pharmacol. Ther. 58, 417–428 (2023).
Google Scholar
De Paepe, K. et al. Modification of wheat bran particle size and tissue composition affects colonisation and metabolism by human faecal microbiota. Food Funct. 10, 379–396 (2019).
Google Scholar
Solvang, M. et al. Beyond purified dietary fibre supplements: compositional variation between cell wall fibre from different plants influences human faecal microbiota activity and growth in vitro. Environ. Microbiol. 25, 1484–1504 (2023).
Google Scholar
Puhlmann, M.-L. et al. Analysis of the fermentation kinetics and gut microbiota modulatory effect of dried chicory root reveals the impact of the plant–cell matrix rationalizing its conversion in the distal colon. Microbiome Res. Rep. 3, 28 (2024).
Google Scholar
La Rosa, S. L. et al. The human gut Firmicute Roseburia intestinalis is a primary degrader of dietary β-mannans. Nat. Commun. 10, 905 (2019). This study provides a deep biochemical characterization of Roseburia intestinalis β-mannan utilization and reveals its competitive behaviour with other gut bacteria both in vitro and in vivo.
Google Scholar
Feng, J. et al. Polysaccharide utilization loci in Bacteroides determine population fitness and community-level interactions. Cell Host Microbe 30, 200–215.e12 (2022). This study reveals the contribution of different polysaccharide utilization loci (PULs) to nutrient-dependent fitness of Bacteroides uniformis PUL mutants and demonstrates their altered cross-feeding interactions with butyrate-producing bacteria.
Google Scholar
Kettle, H., Louis, P. & Flint, H. J. Process-based modelling of microbial community dynamics in the human colon. J. R. Soc. Interface 19, 20220489 (2022).
Google Scholar
Quinn-Bohmann, N. et al. Microbial community-scale metabolic modelling predicts personalized short-chain fatty acid production profiles in the human gut. Nat. Microbiol. 9, 1700–1712 (2024).
Google Scholar
Gibbons, S. M. et al. Perspective: leveraging the gut microbiota to predict personalized responses to dietary, prebiotic, and probiotic interventions. Adv. Nutr. 13, 1450–1461 (2022).
Google Scholar
Cummings, J. H., Pomare, E. W., Branch, W. J., Naylor, C. P. & Macfarlane, G. T. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28, 1221–1227 (1987).
Google Scholar
Fagundes, R. R. et al. Beyond butyrate: microbial fiber metabolism supporting colonic epithelial homeostasis. Trends Microbiol. 32, 178–189 (2024).
Google Scholar
Stumpff, F. A look at the smelly side of physiology: transport of short chain fatty acids. Pflugers Arch. 470, 571–598 (2018).
Google Scholar
Wang, Q. & Mackay, C. R. High metabolite concentrations in portal venous blood as a possible mechanism for microbiota effects on the immune system and Western diseases. J. Allergy Clin. Immunol. 153, 980–982 (2024).
Google Scholar
O’Riordan, K. J. et al. Short chain fatty acids: microbial metabolites for gut–brain axis signalling. Mol. Cell. Endocrinol. 546, 111572 (2022).
Google Scholar
Sukkar, A. H., Lett, A. M., Frost, G. & Chambers, E. S. Regulation of energy expenditure and substrate oxidation by short-chain fatty acids. J. Endocrinol. 242, R1–R8 (2019).
Google Scholar
Priyadarshini, M., Kotlo, K. U., Dudeja, P. K. & Layden, B. T. Role of short chain fatty acid receptors in intestinal physiology and pathophysiology. Compr. Physiol. 8, 1091–1115 (2018).
Google Scholar
Kimura, I., Ichimura, A., Ohue-Kitano, R. & Igarashi, M. Free fatty acid receptors in health and disease. Physiol. Rev. 100, 171–210 (2020).
Google Scholar
Barki, N. et al. Phosphorylation bar-coding of free fatty acid receptor 2 is generated in a tissue-specific manner. eLife 12, RP91861 (2023).
Google Scholar
Bolognini, D., Tobin, A. B., Milligan, G. & Moss, C. E. The pharmacology and function of receptors for short-chain fatty acids. Mol. Pharmacol. 89, 388–398 (2016).
Google Scholar
Stein, R. A. & Riber, L. Epigenetic effects of short-chain fatty acids from the large intestine on host cells. Microlife 4, uqad032 (2023).
Google Scholar
Sarkar, S. et al. Histone deacetylase inhibitors reverse CpG methylation by regulating DNMT1 through ERK signaling. Anticancer Res. 31, 2723–2732 (2011).
Google Scholar
Steliou, K., Boosalis, M. S., Perrine, S. P., Sangerman, J. & Faller, D. V. Butyrate histone deacetylase inhibitors. Biores. Open Access 1, 192–198 (2012).
Google Scholar
He, J. et al. Short-chain fatty acids and their association with signalling pathways in inflammation, glucose and lipid metabolism. Int. J. Mol. Sci. 21, 6356 (2020).
Google Scholar
Rekha, K. et al. Short-chain fatty acid: an updated review on signaling, metabolism, and therapeutic effects. Crit. Rev. Food Sci. Nutr. 64, 2461–2489 (2024).
Google Scholar
Donohoe, D. R. et al. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol. Cell 48, 612–626 (2012).
Google Scholar
Moffett, J. R., Puthillathu, N., Vengilote, R., Jaworski, D. M. & Namboodiri, A. M. Acetate revisited: a key biomolecule at the nexus of metabolism, epigenetics and oncogenesis — part 1: acetyl-CoA, acetogenesis and acyl-CoA short-chain synthetases. Front. Physiol. 11, 580167 (2020).
Google Scholar
Chen, Y. et al. Lysine propionylation and butyrylation are novel post-translational modifications in histones. Mol. Cell. Proteom. 6, 812–819 (2007).
Google Scholar
Fellows, R. et al. Microbiota derived short chain fatty acids promote histone crotonylation in the colon through histone deacetylases. Nat. Commun. 9, 105 (2018).
Google Scholar
Martin-Gallausiaux, C., Marinelli, L., Blottière, H. M., Larraufie, P. & Lapaque, N. SCFA: mechanisms and functional importance in the gut. Proc. Nutr. Soc. 80, 37–49 (2021).
Google Scholar
Modoux, M. et al. Butyrate acts through HDAC inhibition to enhance aryl hydrocarbon receptor activation by gut microbiota-derived ligands. Gut Microbes 14, 2105637 (2022).
Google Scholar
Peng, Y. & Croce, C. M. The role of microRNAs in human cancer. Signal Transduct. Target. Ther. 1, 1–9 (2016).
Hu, S. et al. The microbe-derived short chain fatty acid butyrate targets miRNA-dependent p21 gene expression in human colon cancer. PLoS ONE 6, e16221 (2011).
Google Scholar
Bishop, K. S., Xu, H. & Marlow, G. Epigenetic regulation of gene expression induced by butyrate in colorectal cancer: involvement of microRNA. Genet. Epigenet. 9, 1179237X17729900 (2017).
Google Scholar
Shealy, N. G., Yoo, W. & Byndloss, M. X. Colonization resistance: metabolic warfare as a strategy against pathogenic Enterobacteriaceae. Curr. Opin. Microbiol. 64, 82–90 (2021).
Google Scholar
Shelton, C. D. et al. Salmonella enterica serovar Typhimurium uses anaerobic respiration to overcome propionate-mediated colonization resistance. Cell Rep. 38, 110180 (2022).
Google Scholar
Whisner, C. M. & Castillo, L. F. Prebiotics, bone and mineral metabolism. Calcif. Tissue Int. 102, 443–479 (2018).
Google Scholar
Hyland, N. P. & Cryan, J. F. Microbe–host interactions: influence of the gut microbiota on the enteric nervous system. Dev. Biol. 417, 182–187 (2016).
Google Scholar
Anitha, M., Vijay-Kumar, M., Sitaraman, S. V., Gewirtz, A. T. & Srinivasan, S. Gut microbial products regulate murine gastrointestinal motility via toll-like receptor 4 signaling. Gastroenterology 143, 1006–1016.e4 (2012).
Google Scholar
Zheng, Z., Tang, J., Hu, Y. & Zhang, W. Role of gut microbiota-derived signals in the regulation of gastrointestinal motility. Front. Med. 9, 961703 (2022).
Google Scholar
Sun, Q., Jia, Q., Song, L. & Duan, L. Alterations in fecal short-chain fatty acids in patients with irritable bowel syndrome: a systematic review and meta-analysis. Medicine 98, e14513 (2019).
Google Scholar
Burger-van Paassen, N. et al. The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection. Biochem. J. 420, 211–219 (2009).
Google Scholar
Willemsen, L. E., Koetsier, M. A., van Deventer, S. J. & van Tol, E. A. Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts. Gut 52, 1442–1447 (2003).
Google Scholar
Gaudier, E., Rival, M., Buisine, M. P., Robineau, I. & Hoebler, C. Butyrate enemas upregulate Muc genes expression but decrease adherent mucus thickness in mice colon. Physiol. Res. 58, 111–119 (2009).
Google Scholar
Hamer, H. M. et al. Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission. Clin. Nutr. 29, 738–744 (2010).
Google Scholar
Peng, L., He, Z., Chen, W., Holzman, I. R. & Lin, J. Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier. Pediatr. Res. 61, 37–41 (2007).
Google Scholar
Cresci, G. A. et al. Prophylactic tributyrin treatment mitigates chronic-binge ethanol-induced intestinal barrier and liver injury. J. Gastroenterol. Hepatol. 32, 1587–1597 (2017).
Google Scholar
Tabat, M. W. et al. Acute effects of butyrate on induced hyperpermeability and tight junction protein expression in human colonic tissues. Biomolecules 10, 766 (2020).
Google Scholar
Vancamelbeke, M. et al. Butyrate does not protect against inflammation-induced loss of epithelial barrier function and cytokine production in primary cell monolayers from patients with ulcerative colitis. J. Crohns Colitis 13, 1351–1361 (2019).
Google Scholar
Liu, T. et al. Short-chain fatty acids suppress lipopolysaccharide-induced production of nitric oxide and proinflammatory cytokines through inhibition of NF-κB pathway in RAW264.7 cells. Inflammation 35, 1676–1684 (2012).
Google Scholar
Schulthess, J. et al. The short chain fatty acid butyrate imprints an antimicrobial program in macrophages. Immunity 50, 432–445.e7 (2019). This study provides the mechanistic pathway by which butyrate induces the differentiation of macrophages to exert their antimicrobial function.
Google Scholar
Ji, J. et al. Microbial metabolite butyrate facilitates M2 macrophage polarization and function. Sci. Rep. 6, 24838 (2016).
Google Scholar
Wang, Z. et al. Inulin alleviates inflammation of alcoholic liver disease via SCFAs-inducing suppression of M1 and facilitation of M2 macrophages in mice. Int. Immunopharmacol. 78, 106062 (2020).
Google Scholar
Aguilar, E. C. et al. Butyrate impairs atherogenesis by reducing plaque inflammation and vulnerability and decreasing NFκB activation. Nutr. Metab. Cardiovasc. Dis. 24, 606–613 (2014).
Google Scholar
Zapolska-Downar, D., Siennicka, A., Kaczmarczyk, M., Kolodziej, B. & Naruszewicz, M. Butyrate inhibits cytokine-induced VCAM-1 and ICAM-1 expression in cultured endothelial cells: the role of NF-kappaB and PPARalpha. J. Nutr. Biochem. 15, 220–228 (2004).
Google Scholar
Mills, S. W., Montgomery, S. H. & Morck, D. W. Evaluation of the effects of short-chain fatty acids and extracellular pH on bovine neutrophil function in vitro. Am. J. Vet. Res. 67, 1901–1907 (2006).
Google Scholar
Li, G. et al. Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease. Gut Microbes 13, 1968257 (2021). This study shows that butyrate inhibited the ability of neutrophils isolated from patients with IBD to produce pro-inflammatory cytokines and suppressed neutrophil migration and formation of neutrophil extracellular traps.
Google Scholar
Aoyama, M., Kotani, J. & Usami, M. Butyrate and propionate induced activated or non-activated neutrophil apoptosis via HDAC inhibitor activity but without activating GPR-41/GPR-43 pathways. Nutrition 26, 653–661 (2010).
Google Scholar
Liu, B. et al. Butyrate protects rat liver against total hepatic ischemia reperfusion injury with bowel congestion. PLoS ONE 9, e106184 (2014).
Google Scholar
Simeoli, R. et al. An orally administered butyrate-releasing derivative reduces neutrophil recruitment and inflammation in dextran sulphate sodium-induced murine colitis. Br. J. Pharmacol. 174, 1484–1496 (2017).
Google Scholar
Liu, L. et al. Butyrate interferes with the differentiation and function of human monocyte-derived dendritic cells. Cell. Immunol. 277, 66–73 (2012).
Google Scholar
Kaisar, M. M. M., Pelgrom, L. R., van der Ham, A. J., Yazdanbakhsh, M. & Everts, B. Butyrate conditions human dendritic cells to prime type 1 regulatory T cells via both histone deacetylase inhibition and G protein-coupled receptor 109A signaling. Front. Immunol. 8, 1429 (2017).
Google Scholar
Nastasi, C. et al. The effect of short-chain fatty acids on human monocyte-derived dendritic cells. Sci. Rep. 5, 16148 (2015).
Google Scholar
Tao, R. et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat. Med. 13, 1299–1307 (2007).
Google Scholar
Arpaia, N. et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451–455 (2013).
Google Scholar
Park, J. et al. Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR–S6K pathway. Mucosal Immunol. 8, 80–93 (2015).
Google Scholar
Kespohl, M. et al. The microbial metabolite butyrate induces expression of Th1-associated factors in CD4(+) T cells. Front. Immunol. 8, 1036 (2017).
Google Scholar
Luu, M. et al. Regulation of the effector function of CD8(+) T cells by gut microbiota-derived metabolite butyrate. Sci. Rep. 8, 14430 (2018).
Google Scholar
Kim, M., Qie, Y., Park, J. & Kim, C. H. Gut microbial metabolites fuel host antibody responses. Cell Host Microbe 20, 202–214 (2016).
Google Scholar
Wu, W. et al. Microbiota metabolite short-chain fatty acid acetate promotes intestinal IgA response to microbiota which is mediated by GPR43. Mucosal Immunol. 10, 946–956 (2017).
Google Scholar
Sanchez, H. N. et al. B cell-intrinsic epigenetic modulation of antibody responses by dietary fiber-derived short-chain fatty acids. Nat. Commun. 11, 60 (2020).
Google Scholar
Luu, M., Monning, H. & Visekruna, A. Exploring the molecular mechanisms underlying the protective effects of microbial SCFAs on intestinal tolerance and food allergy. Front. Immunol. 11, 1225 (2020).
Google Scholar
Daien, C. I. et al. Gut-derived acetate promotes B10 cells with antiinflammatory effects. JCI Insight 6, e144156 (2021). This study shows that acetate induces proliferation of IL-10 producing regulatory B cells (B10 cells) in both in vivo and in vitro models, outlining its anti-inflammatory role.
Google Scholar
Cong, J., Zhou, P. & Zhang, R. Intestinal microbiota-derived short chain fatty acids in host health and disease. Nutrients 14, 1977 (2022).
Google Scholar
Mukhopadhya, I., Hansen, R., El-Omar, E. M. & Hold, G. L. IBD — what role do Proteobacteria play? Nat. Rev. Gastroenterol. Hepatol. 9, 219–230 (2012).
Google Scholar
Machiels, K. et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 63, 1275–1283 (2014).
Google Scholar
Kowalska-Duplaga, K. et al. Differences in the intestinal microbiome of healthy children and patients with newly diagnosed Crohn’s disease. Sci. Rep. 9, 18880 (2019).
Google Scholar
Laserna-Mendieta, E. J. et al. Determinants of reduced genetic capacity for butyrate synthesis by the gut microbiome in Crohn’s disease and ulcerative colitis. J. Crohns Colitis 12, 204–216 (2018).
Google Scholar
Xu, H. M. et al. Characterization of short-chain fatty acids in patients with ulcerative colitis: a meta-analysis. BMC Gastroenterol. 22, 117 (2022). This meta-analysis of 11 studies shows that patients with ulcerative colitis had significantly decreased concentration of acetate and propionate as opposed to healthy controls.
Google Scholar
De Preter, V. et al. Kinetics of butyrate metabolism in the normal colon and in ulcerative colitis: the effects of substrate concentration and carnitine on the β‐oxidation pathway. Aliment. Pharmacol. Ther. 34, 526–532 (2011).
Google Scholar
Ferrer-Picón, E. et al. Intestinal inflammation modulates the epithelial response to butyrate in patients with inflammatory bowel disease. Inflamm. Bowel Dis. 26, 43–55 (2020).
Google Scholar
Starr, A. E. et al. Associations between cellular energy and pediatric inflammatory bowel disease patient response to treatment. J. Proteome Res. 20, 4393–4404 (2021).
Google Scholar
Kaczmarczyk, O. et al. Altered fecal short-chain fatty acid profile as a potential marker of disease activity in patients with ulcerative colitis and Crohn’s disease: a pilot study. Pol. Arch. Intern. Med. 132, 16254 (2022).
Google Scholar
Zhuang, X. et al. Systematic review and meta-analysis: short-chain fatty acid characterization in patients with inflammatory bowel disease. Inflamm. Bowel Dis. 25, 1751–1763 (2019).
Google Scholar
Vernia, P. et al. Short‐chain fatty acid topical treatment in distal ulcerative colitis. Aliment. Pharmacol. Ther. 9, 309–313 (1995).
Google Scholar
Scheppach, W. et al. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology 103, 51–56 (1992).
Google Scholar
Lührs, H. et al. Butyrate inhibits NF-κB activation in lamina propria macrophages of patients with ulcerative colitis. Scand. J. Gastroenterol. 37, 458–466 (2002).
Google Scholar
Jamka, M. et al. The effect of sodium butyrate enemas compared with placebo on disease activity, endoscopic scores, and histological and inflammatory parameters in inflammatory bowel diseases: a systematic review of randomised controlled trials. Complement. Med. Res. 28, 344–356 (2021).
Google Scholar
Sabatino, A. et al. Oral butyrate for mildly to moderately active Crohn’s disease. Aliment. Pharmacol. Ther. 22, 789–794 (2005).
Google Scholar
Vernia, P. et al. Combined oral sodium butyrate and mesalazine treatment compared to oral mesalazine alone in ulcerative colitis. Dig. Dis. Sci. 45, 976–981 (2000).
Google Scholar
Bray, F. et al. Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394–424 (2018).
Google Scholar
Reynolds, A. et al. Carbohydrate quality and human health: a series of systematic reviews and meta-analyses. Lancet 393, 434–445 (2019).
Google Scholar
Bingham, S. A. et al. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet 361, 1496–1501 (2003).
Google Scholar
Yusuf, F., Adewiah, S., Syam, A. F. & Fatchiyah, F. Altered profile of gut microbiota and the level short chain fatty acids in colorectal cancer patients. J. Phys. Conf. Ser. 1146, 012037 (2019).
Google Scholar
Shuwen, H. et al. Protective effect of the ‘food–microorganism–SCFAs’ axis on colorectal cancer: from basic research to practical application. J. Cancer Res. Clin. Oncol. 145, 2169–2197 (2019).
Google Scholar
Vinelli, V. et al. Effects of dietary fibers on short-chain fatty acids and gut microbiota composition in healthy adults: a systematic review. Nutrients 14, 2559 (2022).
Google Scholar
Gold, A., Choueiry, F., Jin, N., Mo, X. & Zhu, J. The application of metabolomics in recent colorectal cancer studies: a state-of-the-art review. Cancers 14, 725 (2022).
Google Scholar
Louis, P., Hold, G. L. & Flint, H. J. The gut microbiota, bacterial metabolites and colorectal cancer. Nat. Rev. Microbiol. 12, 661–672 (2014).
Google Scholar
Scharlau, D. et al. Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fibre. Mutat. Res. 682, 39–53 (2009).
Google Scholar
Kim, Y.-H., Park, J.-W., Lee, J.-Y. & Kwon, T. K. Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells. Carcinogenesis 25, 1813–1820 (2004).
Google Scholar
Waby, J. S. et al. Sp1 acetylation is associated with loss of DNA binding at promoters associated with cell cycle arrest and cell death in a colon cell line. Mol. Cancer 9, 1–16 (2010).
Google Scholar
Eslami, M. et al. Importance of the microbiota inhibitory mechanism on the Warburg effect in colorectal cancer cells. J. Gastrointest. Cancer 51, 738–747 (2020).
Google Scholar
Luo, Q., Zhou, P., Chang, S., Huang, Z. & Zeng, X. Characterization of butyrate-metabolism in colorectal cancer to guide clinical treatment. Sci. Rep. 13, 5106 (2023). This study utilizes expression of butyrate metabolism-related genes in CRC samples to develop a risk prognostic model that could forecast the response of these patients to immunotherapy and chemotherapy.
Google Scholar
Ho, M. H.-K., Wong, W. H.-S. & Chang, C. Clinical spectrum of food allergies: a comprehensive review. Clin. Rev. Allergy Immunol. 46, 225–240 (2014).
Google Scholar
Sicherer, S. H. & Sampson, H. A. Food allergy: epidemiology, pathogenesis, diagnosis, and treatment. J. Allergy Clin. Immunol. 133, 291–307.e5 (2014).
Google Scholar
Stefka, A. T. et al. Commensal bacteria protect against food allergen sensitization. Proc. Natl Acad. Sci. USA 111, 13145–13150 (2014).
Google Scholar
Liu, S., Yang, B., Yang, P. & Liu, Z. Herbal formula-3 ameliorates OVA-induced food allergy in mice may via modulating the gut microbiota. Am. J. Transl. Res. 11, 5812–5823 (2019).
Google Scholar
Takahashi, H. et al. Combined oral intake of short and long fructans alters the gut microbiota in food allergy model mice and contributes to food allergy prevention. BMC Microbiol. 23, 266 (2023).
Google Scholar
De Paepe, E., Van Gijseghem, L., De Spiegeleer, M., Cox, E. & Vanhaecke, L. A systematic review of metabolic alterations underlying IgE‐mediated food allergy in children. Mol. Nutr. Food Res. 65, e2100536 (2021).
Google Scholar
Sasaki, M. et al. Systematic review of the association between short‐chain fatty acids and allergic diseases. Allergy 79, 1789–1811 (2024).
Google Scholar
Son, M.-Y. & Cho, H.-S. Anticancer effects of gut microbiota-derived short-chain fatty acids in cancers. J. Microbiol. Biotechnol. 33, 849–856 (2023).
Google Scholar
Yang, Q. et al. A review of gut microbiota‐derived metabolites in tumor progression and cancer therapy. Adv. Sci. 10, e2207366 (2023).
Google Scholar
Sun, J. et al. Butyrate as a promising therapeutic target in cancer: from pathogenesis to clinic (review). Int. J. Oncol. 64, 44 (2024).
Google Scholar
Mayorga-Ramos, A., Barba-Ostria, C., Simancas-Racines, D. & Guamán, L. P. Protective role of butyrate in obesity and diabetes: new insights. Front. Nutr. 9, 1067647 (2022).
Google Scholar
Evans, C. E. L. et al. Effects of dietary fibre type on blood pressure. J. Hypertens. 33, 897–911 (2015).
Google Scholar
Marques, F. Z. et al. High-fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice. Circulation 135, 964–977 (2017).
Google Scholar
Karbach, S. H. et al. Gut microbiota promote angiotensin II-induced arterial hypertension and vascular dysfunction. J. Am. Heart Assoc. 5, e003698 (2016).
Google Scholar
Roshanravan, N. et al. Effect of butyrate and inulin supplementation on glycemic status, lipid profile and glucagon-like peptide 1 level in patients with type 2 diabetes: a randomized double-blind, placebo-controlled trial. Horm. Metab. Res. 49, 886–891 (2017).
Google Scholar
Verhaar, B. et al. Oral sodium butyrate increases daytime systolic blood pressure in hypertensive patients: a double-blind, randomized, placebo-controlled trial. J. Hypertens. 41, e77 (2023).
Google Scholar
Verhaar, B. J. H. et al. Effects of oral butyrate on blood pressure in patients with hypertension: a randomized, placebo-controlled trial. Hypertension 81, 2124–2136 (2024).
Google Scholar
Jie, Z. et al. The gut microbiome in atherosclerotic cardiovascular disease. Nat. Commun. 8, 845 (2017).
Google Scholar
Zhou, M. et al. The short-chain fatty acid propionate improved ventricular electrical remodeling in a rat model with myocardial infarction. Food Funct. 12, 12580–12593 (2021).
Google Scholar
Jiang, X., Huang, X., Tong, Y. & Gao, H. Butyrate improves cardiac function and sympathetic neural remodeling following myocardial infarction in rats. Can. J. Physiol. Pharmacol. 98, 391–399 (2020).
Google Scholar
Chambers, E. S. et al. Acute oral sodium propionate supplementation raises resting energy expenditure and lipid oxidation in fasted humans. Diabetes Obes. Metab. 20, 1034–1039 (2018).
Google Scholar
Canfora, E. E. et al. Colonic infusions of short-chain fatty acid mixtures promote energy metabolism in overweight/obese men: a randomized crossover trial. Sci. Rep. 7, 2360 (2017).
Google Scholar
Eslick, S., Thompson, C., Berthon, B. & Wood, L. Short-chain fatty acids as anti-inflammatory agents in overweight and obesity: a systematic review and meta-analysis. Nutr. Rev. 80, 838–856 (2022).
Google Scholar
Bouter, K. E. C. et al. Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects. Clin. Transl. Gastroenterol. 9, e155 (2018).
Google Scholar
Khosravi, Z. et al. The effects of butyrate supplementation on glycemic control, lipid profile, blood pressure, nitric oxide level and glutathione peroxidase activity in type 2 diabetic patients: a randomized triple-blind, placebo-controlled trial. Clin. Nutr. ESPEN 49, 79–85 (2022).
Google Scholar
de Groot, P. F. et al. Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes: a randomised controlled trial. Diabetologia 63, 597–610 (2020).
Google Scholar
Coppola, S. et al. Therapeutic effects of butyrate on pediatric obesity: a randomized clinical trial. JAMA Netw. Open 5, e2244912 (2022).
Google Scholar
Byrne, C. S., Chambers, E. S., Morrison, D. J. & Frost, G. The role of short chain fatty acids in appetite regulation and energy homeostasis. Int. J. Obes. 39, 1331–1338 (2015).
Google Scholar
Haspeslagh, E., Heyndrickx, I., Hammad, H. & Lambrecht, B. N. The hygiene hypothesis: immunological mechanisms of airway tolerance. Curr. Opin. Immunol. 54, 102–108 (2018).
Google Scholar
Roduit, C. et al. High levels of butyrate and propionate in early life are associated with protection against atopy. Allergy 74, 799–809 (2019).
Google Scholar
Russell, S. L. et al. Early life antibiotic‐driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep. 13, 440–447 (2012).
Google Scholar
Cait, A. et al. Microbiome-driven allergic lung inflammation is ameliorated by short-chain fatty acids. Mucosal Immunol. 11, 785–795 (2018).
Google Scholar
Depner, M. et al. Maturation of the gut microbiome during the first year of life contributes to the protective farm effect on childhood asthma. Nat. Med. 26, 1766–1775 (2020).
Google Scholar
Verma, A. et al. Short-chain fatty acid (SCFA) as a connecting link between microbiota and gut–lung axis — a potential therapeutic intervention to improve lung health. ACS Omega 9, 14648–14671 (2024).
Google Scholar
Mirzaei, R. et al. Role of microbiota-derived short-chain fatty acids in nervous system disorders. Biomed. Pharmacother. 139, 111661 (2021).
Google Scholar
Li, H. et al. Gut microbiota changes in patients with Alzheimer’s disease spectrum based on 16S rRNA sequencing: a systematic review and meta-analysis. Front. Aging Neurosci. 16, 1422350 (2024).
Google Scholar
Matt, S. M. et al. Butyrate and dietary soluble fiber improve neuroinflammation associated with aging in mice. Front. Immunol. 9, 1832 (2018).
Google Scholar
Fernando, W. M. A. D. B. et al. Sodium butyrate reduces brain amyloid-β levels and improves cognitive memory performance in an Alzheimer’s disease transgenic mouse model at an early disease stage. J. Alzheimers Dis. 74, 91–99 (2020).
Google Scholar
Nishiwaki, H. et al. Meta‐analysis of gut dysbiosis in Parkinson’s disease. Mov. Disord. 35, 1626–1635 (2020).
Google Scholar
Nishiwaki, H. et al. Meta-analysis of shotgun sequencing of gut microbiota in Parkinson’s disease. NPJ Parkinsons Dis. 10, 106 (2024).
Google Scholar
Liu, J. et al. Sodium butyrate exerts protective effect against Parkinson’s disease in mice via stimulation of glucagon like peptide-1. J. Neurol. Sci. 381, 176–181 (2017).
Google Scholar
Guo, T.-T. et al. Neuroprotective effects of sodium butyrate by restoring gut microbiota and inhibiting TLR4 signaling in mice with MPTP-induced Parkinson’s disease. Nutrients 15, 930 (2023).
Google Scholar
Zeng, Q. et al. Gut dysbiosis and lack of short chain fatty acids in a Chinese cohort of patients with multiple sclerosis. Neurochem. Int. 129, 104468 (2019).
Google Scholar
Duscha, A. et al. Propionic acid shapes the multiple sclerosis disease course by an immunomodulatory mechanism. Cell 180, 1067–1080.e16 (2020).
Google Scholar
Chen, T., Noto, D., Hoshino, Y., Mizuno, M. & Miyake, S. Butyrate suppresses demyelination and enhances remyelination. J. Neuroinflammation 16, 1–13 (2019).
Google Scholar
Chevalier, A. C. & Rosenberger, T. A. Increasing acetyl‐CoA metabolism attenuates injury and alters spinal cord lipid content in mice subjected to experimental autoimmune encephalomyelitis. J. Neurochem. 141, 721–737 (2017).
Google Scholar
Mizuno, M., Noto, D., Kaga, N., Chiba, A. & Miyake, S. The dual role of short fatty acid chains in the pathogenesis of autoimmune disease models. PLoS ONE 12, e0173032 (2017).
Google Scholar
Macfarlane, G. T., Gibson, G. R. & Cummings, J. H. Comparison of fermentation reactions in different regions of the human colon. J. Appl. Bacteriol. 72, 57–64 (1992).
Google Scholar
van der Beek, C. M. et al. Hepatic uptake of rectally administered butyrate prevents an increase in systemic butyrate concentrations in humans. J. Nutr. 145, 2019–2024 (2015).
Google Scholar
van der Beek, C. M. et al. Distal, not proximal, colonic acetate infusions promote fat oxidation and improve metabolic markers in overweight/obese men. Clin. Sci. 130, 2073–2082 (2016).
Google Scholar
Edelman, M. J. et al. Clinical and pharmacologic study of tributyrin: an oral butyrate prodrug. Cancer Chemother. Pharmacol. 51, 439–444 (2003).
Google Scholar
Donovan, J. D., Bauer, L., Fahey, G. C. & Lee, Y. In vitro digestion and fermentation of microencapsulated tributyrin for the delivery of butyrate. J. Food Sci. 82, 1491–1499 (2017).
Google Scholar
Di Sabatino, A. et al. Efficacy of butyrate in the treatment of mild to moderate Crohn’s disease. Dig. Liver Dis. Suppl. 1, 31–35 (2007).
Annison, G., Illman, R. J. & Topping, D. L. Acetylated, propionylated or butyrylated starches raise large bowel short-chain fatty acids preferentially when fed to rats. J. Nutr. 133, 3523–3528 (2003).
Google Scholar
Mariño, E. et al. Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes. Nat. Immunol. 18, 552–562 (2017).
Google Scholar
Clarke, J. M. et al. Butyrate esterified to starch is released in the human gastrointestinal tract. Am. J. Clin. Nutr. 94, 1276–1283 (2011).
Google Scholar
Le Leu, R. K. et al. Butyrylated starch intake can prevent red meat-induced O6-methyl-2-deoxyguanosine adducts in human rectal tissue: a randomised clinical trial. Br. J. Nutr. 114, 220–230 (2015).
Google Scholar
Hutkins, R. et al. Classifying compounds as prebiotics — scientific perspectives and recommendations. Nat. Rev. Gastroenterol. Hepatol. 22, 54–70 (2025).
Google Scholar
Wolever, T. M., ter Wal, P., Spadafora, P. & Robb, P. Guar, but not psyllium, increases breath methane and serum acetate concentrations in human subjects. Am. J. Clin. Nutr. 55, 719–722 (1992).
Google Scholar
Rahat-Rozenbloom, S., Fernandes, J., Cheng, J., Gloor, G. B. & Wolever, T. M. S. The acute effects of inulin and resistant starch on postprandial serum short-chain fatty acids and second-meal glycemic response in lean and overweight humans. Eur. J. Clin. Nutr. 71, 227–233 (2017).
Google Scholar
Markowiak-Kopeć, P. & Śliżewska, K. The effect of probiotics on the production of short-chain fatty acids by human intestinal microbiome. Nutrients 12, 1107 (2020).
Google Scholar
El-Salhy, M., Valeur, J., Hausken, T. & Gunnar Hatlebakk, J. Changes in fecal short-chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome. Neurogastroenterol. Motil. 33, e13983 (2021).
Google Scholar
Smits, L. P., Bouter, K. E. C., de Vos, W. M., Borody, T. J. & Nieuwdorp, M. Therapeutic potential of fecal microbiota transplantation. Gastroenterology 145, 946–953 (2013).
Google Scholar
Arnold, J., Glazier, J. & Mimee, M. Genetic engineering of resident bacteria in the gut microbiome. J. Bacteriol. 205, e0012723 (2023). This mini-review highlights recent progress in genetic engineering to create designer bacteria that produce metabolites capable of impacting host health and creating novel biotherapeutics.
Google Scholar
Vázquez-Castellanos, J. F., Biclot, A., Vrancken, G., Huys, G. R. & Raes, J. Design of synthetic microbial consortia for gut microbiota modulation. Curr. Opin. Pharmacol. 49, 52–59 (2019).
Google Scholar
Pereira, F. C. & Berry, D. Microbial nutrient niches in the gut. Environ. Microbiol. 19, 1366–1378 (2017).
Google Scholar
Letourneau, J. et al. Interplay between particle size and microbial ecology in the gut microbiome. ISME J. 18, wrae168 (2024).
Google Scholar
Shetty, S. A. et al. Dynamic metabolic interactions and trophic roles of human gut microbes identified using a minimal microbiome exhibiting ecological properties. ISME J. 16, 2144–2159 (2022).
Google Scholar
O’Keefe, S. J. D. et al. Fat, fibre and cancer risk in African Americans and rural Africans. Nat. Commun. 6, 6342 (2015).
Google Scholar
Tannock, G. W. Understanding the gut microbiota by considering human evolution: a story of fire, cereals, cooking, molecular ingenuity, and functional cooperation. Microbiol. Mol. Biol. Rev. 88, e0012722 (2024).
Google Scholar
Sonnenburg, E. D. & Sonnenburg, J. L. The ancestral and industrialized gut microbiota and implications for human health. Nat. Rev. Microbiol. 17, 383–390 (2019).
Google Scholar
O’Keefe, S. J. The association between dietary fibre deficiency and high-income lifestyle-associated diseases: Burkitt’s hypothesis revisited. Lancet Gastroenterol. Hepatol. 4, 984–996 (2019).
Google Scholar
Ramsteijn, A. S. & Louis, P. Dietary fibre optimisation in support of global health. Microb. Biotechnol. 17, e14542 (2024).
Google Scholar
Taras, D., Simmering, R., Collins, M. D., Lawson, P. A. & Blaut, M. Reclassification of Eubacterium formicigenerans Holdeman and Moore 1974 as Dorea formicigenerans gen. nov., comb. nov., and description of Dorea longicatena sp. nov., isolated from human faeces. Int. J. Syst. Evol. Microbiol. 52, 423–428 (2002).
Google Scholar
Holdeman, L. V. & Moore, W. E. C. New genus, Coprococcus, twelve new species, and emended descriptions of four previously described species of bacteria from human feces. Int. J. Syst. Bacteriol. 24, 260–277 (1974).
Google Scholar
Togo, A. H. et al. Description of Mediterraneibacter massiliensis, gen. nov., sp. nov., a new genus isolated from the gut microbiota of an obese patient and reclassification of Ruminococcus faecis, Ruminococcus lactaris, Ruminococcus torques, Ruminococcus gnavus and Clostridium glycyrrhizinilyticum as Mediterraneibacter faecis comb. nov., Mediterraneibacter lactaris comb. nov., Mediterraneibacter torques comb. nov., Mediterraneibacter gnavus comb. nov. and Mediterraneibacter glycyrrhizinilyticus comb. nov. Antonie van Leeuwenhoek 111, 2107–2128 (2018).
Google Scholar
Flaiz, M. et al. Refining and illuminating acetogenic Eubacterium strains for reclassification and metabolic engineering. Microb. Cell Fact. 23, 24 (2024).
Google Scholar
Trischler, R., Roth, J., Sorbara, M. T., Schlegel, X. & Müller, V. A functional Wood–Ljungdahl pathway devoid of a formate dehydrogenase in the gut acetogens Blautia wexlerae, Blautia luti and beyond. Environ. Microbiol. 24, 3111–3123 (2022).
Google Scholar
Zhang, B., Lingga, C., De Groot, H. & Hackmann, T. J. The oxidoreductase activity of Rnf balances redox cofactors during fermentation of glucose to propionate in Prevotella. Sci. Rep. 13, 16429 (2023).
Google Scholar
Robert, C. & Bernalier-Donadille, A. The cellulolytic microflora of the human colon: evidence of microcrystalline cellulose-degrading bacteria in methane-excreting subjects. FEMS Microbiol. Ecol. 46, 81–89 (2003).
Google Scholar
Kettle, H., Louis, P., Holtrop, G., Duncan, S. H. & Flint, H. J. Modelling the emergent dynamics and major metabolites of the human colonic microbiota. Environ. Microbiol. 17, 1615–1630 (2015).
Google Scholar
Gupta, R. S., Nanda, A. & Khadka, B. Novel molecular, structural and evolutionary characteristics of the phosphoketolases from bifidobacteria and Coriobacteriales. PLoS ONE 12, e0172176 (2017).
Google Scholar
Guillemot, F. et al. Treatment of diversion colitis by short-chain fatty acids: prospective and double-blind study. Dis. Colon Rectum 34, 861–864 (1991).
Google Scholar
Patz, J., Jacobsohn, W. Z., Gottschalk-Sabag, S., Zeides, S. & Braverman, D. Z. Treatment of refractory distal ulcerative colitis with short chain fatty acid enemas. Am. J. Gastroenterol. 91, 731–734 (1996).
Google Scholar
Steinhart, A. H., Hiruki, T., Brzezinski, A. & Baker, J. P. Treatment of left‐sided ulcerative colitis with butyrate enemas: a controlled trial. Aliment. Pharmacol. Ther. 10, 729–736 (1996).
Google Scholar
Scheppach, W. et al. Histological changes in the colonic mucosa following irrigation with short-chain fatty acids. Eur. J. Gastroenterol. Hepatol. 9, 163–168 (1997).
Google Scholar
Scheppach, W. & Group, G.-A. S. S. Treatment of distal ulcerative colitis with short-chain fatty acid enemas a placebo-controlled trial. Dig. Dis. Sci. 41, 2254–2259 (1996).
Google Scholar
Breuer, R. I. et al. Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial. Gut 40, 485–491 (1997).
Google Scholar
Schauber, J. et al. Local short-chain fatty acids supplementation without beneficial effect on inflammation in excluded rectum. Scand. J. Gastroenterol. 35, 184–189 (2000).
Google Scholar
Vernia, P. et al. Topical butyrate for acute radiation proctitis: randomised, crossover trial. Lancet 356, 1232–1235 (2000).
Google Scholar
Scarpellini, E. et al. Efficacy of butyrate in the treatment of diarrhoea-predominant irritable bowel syndrome. Dig. Liver Dis. Suppl. 1, 19–22 (2007).
Vernero, M. et al. The usefulness of microencapsulated sodium butyrate add-on therapy in maintaining remission in patients with ulcerative colitis: a prospective observational study. J. Clin. Med. 9, 3941 (2020).
Google Scholar
Pietrzak, A. et al. Sodium butyrate effectiveness in children and adolescents with newly diagnosed inflammatory bowel diseases — randomized placebo-controlled multicenter trial. Nutrients 14, 3283 (2022).
Google Scholar
Buckel, W. & Thauer, R. K. Flavin-based electron bifurcation, a new mechanism of biological energy coupling. Chem. Rev. 118, 3862–3886 (2018).
Google Scholar
link
